REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 106 filers reported holding REPLIMUNE GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,465,703 | -18.0% | 1,430,025 | +11.3% | 0.01% | -20.0% |
| Q2 2023 | $29,824,541 | +56.9% | 1,284,449 | +19.3% | 0.01% | +66.7% |
| Q1 2023 | $19,010,269 | +96178.9% | 1,076,483 | +48.3% | 0.01% | 0.0% |
| Q4 2022 | $19,745 | -99.8% | 725,888 | +12.1% | 0.01% | +50.0% |
| Q3 2022 | $11,178,000 | +35.2% | 647,356 | +36.8% | 0.00% | +33.3% |
| Q2 2022 | $8,269,000 | +41.4% | 473,056 | +37.4% | 0.00% | +50.0% |
| Q1 2022 | $5,848,000 | -7.2% | 344,397 | +48.1% | 0.00% | 0.0% |
| Q4 2021 | $6,301,000 | +21.2% | 232,477 | +32.6% | 0.00% | 0.0% |
| Q3 2021 | $5,198,000 | +100.2% | 175,360 | +159.6% | 0.00% | +100.0% |
| Q2 2021 | $2,596,000 | +155.0% | 67,552 | +102.8% | 0.00% | – |
| Q1 2021 | $1,018,000 | -19.1% | 33,310 | +1.4% | 0.00% | – |
| Q4 2020 | $1,258,000 | +66.2% | 32,856 | 0.0% | 0.00% | – |
| Q3 2020 | $757,000 | +138.8% | 32,856 | +157.6% | 0.00% | – |
| Q2 2020 | $317,000 | – | 12,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,103,455 | $82,166,000 | 38.87% |
| Bain Capital Life Sciences Investors, LLC | 2,838,968 | $45,707,000 | 10.37% |
| Foresite Capital Management IV, LLC | 1,229,656 | $19,797,000 | 6.49% |
| Foresite Capital Management III, LLC | 779,656 | $12,552,000 | 2.77% |
| BVF INC/IL | 911,852 | $14,681,000 | 1.29% |
| Redmile Group, LLC | 2,192,957 | $35,307,000 | 1.09% |
| Cormorant Asset Management, LP | 467,792 | $7,531,000 | 0.49% |
| DC Investments Management, LLC | 39,578 | $637,000 | 0.43% |
| EMERALD ADVISERS, LLC | 618,080 | $9,951,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 523,316 | $8,425,000 | 0.28% |